Trials Methodology Research: what is it and why should India invest in it?
| dc.contributor.author | Sangeetha Paramasivana | |
| dc.contributor.author | Anant Bhan | |
| dc.contributor.author | Rashmi Rodrigues | |
| dc.contributor.author | Usha Menon | |
| dc.date.accessioned | 2024-12-07T05:05:47Z | |
| dc.date.available | 2024-12-07T05:05:47Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | This Viewpoint presents an overview of trials methodology research (TMR) and the case for investing in TMR in India. | |
| dc.identifier.uri | https://resourcerepository.azimpremjiuniversity.edu.in/handle/apurr/1223 | |
| dc.publisher | The Lancet Regional Health Southeast Asia | |
| dc.source.uri | https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00010-6/fulltext | |
| dc.subject | Health financing | |
| dc.subject | Public health | |
| dc.title | Trials Methodology Research: what is it and why should India invest in it? | |
| dc.type | Article |